Know Cancer

or
forgot password

Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy


N/A
N/A
N/A
Open (Enrolling)
Both
Neoplasm

Thank you

Trial Information

Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy


Background:

-This protocol acknowledges that it is in the interest of the NIH and ROB, as well as our
patients, to continue to follow those who have been treated with radiotherapy at ROB and are
not otherwise eligible for current active research protocols.

It also provides a mechanism for the correlation and interpretation of disparate data for
research into the long term side effects and outcomes for a variety of disease entities and
treatments, such as combined modality treatment, MoAb, PDT, radiation modifiers,
intraoperative radiotherapy, etc.

Objectives:

-The objective of this protocol is to provide follow-up care for patients previously treated
with radiotherapy in the Radiation Oncology Branch (ROB) in order to assess the late effects
of treatment and the natural history of disease.

Eligibility:

-Patients who received radiation therapy at the NCI IRB who are long-term survivors and are
not currently entered on an active research protocol.

Design:

-This is a natural history protocol that will provide follow-up care for Radiation Oncology
Branch patients and will allow for appropriate long-term follow up care and evaluation,
including NIH consultation services as required. It will be made clear to patients in the
consent form, that data collected in their follow-up may be used anonymously for
publications concerning the natural history of disease processes and long term effects of
treatment.

Inclusion Criteria


- INCLUSION CRITERIA:

Radiation Oncology Branch investigator deems that it is in the best interests of the
patient and the NCI/ROB for the patient to be seen in follow-up in the ROB clinic.

Patient or guardian is able to provide informed consent.

Patient must have a primary physician in the community to whom records and appropriate
follow-up management can be given. Social services will be enlisted for any patients who
lack health insurance, etc.

Patients who have received radiotherapy in the ROB and may or may not be officially
entered on a clinical protocol. Some patients treated prior to 1993 may not have been
officially entered on a clinical protocol.

EXCLUSION CRITERIA:

Patients who are on another active primary research protocol at NIH.

Type of Study:

Observational

Study Design:

N/A

Principal Investigator

Kevin A Camphausen, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

National Cancer Institute (NCI)

Authority:

United States: Federal Government

Study ID:

000074

NCT ID:

NCT00026650

Start Date:

February 2000

Completion Date:

Related Keywords:

  • Neoplasm
  • Follow-Up
  • Long-Term
  • Radiation
  • Side-Effects
  • Therapy
  • Neoplasms

Name

Location

National Institutes of Health Clinical Center, 9000 Rockville PikeBethesda, Maryland  20892